Skip to main content
. 2019 Dec;11(12):5071–5078. doi: 10.21037/jtd.2019.11.78

Table 1. Clinicopathologic factors related to BRAF mutation in 1,199 patients with PTC.

Clinicopathologic factors BRAF (+) BRAF (−) χ2/t-test P Spearman P
Age (years) 791 408 0.608 0.436 0.099 0.001
   Mean ± SD 43.8±12.0 46.7±13.0 <0.001
   ≤45 433 180
   >45 358 228
Sex 791 408 268.1 <0.001 −0.052 0.074
   Male 195 121
   Female 596 287
Tumor size (cm) 888 427 22.2 <0.001 0.031 0.264
   Mean ± SD 0.82±0.49 0.86±0.56 <0.001
   <1.0 688 320
   ≥1.0 200 107
Multiplicity 134.7 <0.001 0.040 0.151
   Absent 884 427
   Present 4 0
Bilaterality 158.2 <0.001 0.108 0.001
   Absent 791 408
   Present 97 19

PTC, papillary thyroid carcinoma.